Oak Therapeutics

Oak Therapeutics announces results of bioequivalence study of company’s oral dissolvable strip for TB

By Oak Therapeutics
Published: Oct. 4, 2017, 11:44 p.m.· Tags: Pediatrics, Treatment, Scientific research

Results of in vivo study signifies completion of another critical milestone in company’s Phase I of NIAID contract* to develop ODS strip for anti-tuberculosis treatment option.

Read More →

Page 1 of 1 · Total posts: 1

1